{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:02:35Z","timestamp":1770512555842,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nrneurol.2015.192","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T10:17:46Z","timestamp":1444731466000},"page":"646-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Progress in inflammatory neuropathy \u2014the legacy of Dr Jack Griffin"],"prefix":"10.1038","volume":"11","author":[{"given":"Eva L.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A. C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"BFnrneurol2015192_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"GM McKhann","year":"1993","unstructured":"McKhann, G. M. et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33, 333\u2013342 (1993).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C. E. et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39, 625\u2013635 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI37338","volume":"119","author":"KN Greenshields","year":"2009","unstructured":"Greenshields, K. N. et al. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J. Clin. Invest. 119, 595\u2013610 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2015192_CR4","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/brain\/awq119","volume":"133","author":"R McGonigal","year":"2010","unstructured":"McGonigal, R. et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133, 1944\u20131960 (2010).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","volume":"54","author":"K Susuki","year":"2003","unstructured":"Susuki, K. et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol. 54, 383\u2013388 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki, N. et al. Animal model of axonal Guillain\u2013Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49, 712\u2013720 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"JW Griffin","year":"1996","unstructured":"Griffin, J. W. et al. Pathology of the motor\u2013sensory axonal Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 39, 17\u201328 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin, J. W. et al. Guillain\u2013Barr\u00e9 syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118, 577\u2013595 (1995).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02284784","volume":"25","author":"JW Griffin","year":"1996","unstructured":"Griffin, J. W. et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain\u2013Barr\u00e9 syndrome. J. Neurocytol. 25, 33\u201351 (1996).","journal-title":"J. Neurocytol."},{"key":"BFnrneurol2015192_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C. et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40, 635\u2013644 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.48.3.695","volume":"48","author":"TW Ho","year":"1997","unstructured":"Ho, T. W. et al. Patterns of recovery in the Guillain\u2013Barr\u00e9 syndromes. Neurology 48, 695\u2013700 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","volume":"45","author":"TW Ho","year":"1999","unstructured":"Ho, T. W. et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 45, 168\u2013173 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410230503","volume":"23","author":"AA Ilyas","year":"1988","unstructured":"Ilyas, A. A. et al. Serum antibodies to gangliosides in Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 23, 440\u2013447 (1988).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho, T. W. et al. Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597\u2013605 (1995).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden, R. D. et al. Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group. Ann. Neurol. 44, 780\u2013788 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes, R. A. & Cornblath, D. R. Guillain\u2013Barr\u00e9 syndrome. Lancet 366, 1653\u20131666, (2005).","journal-title":"Lancet"},{"key":"BFnrneurol2015192_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","volume":"74","author":"Z Islam","year":"2010","unstructured":"Islam, Z. et al. Axonal variant of Guillain\u2013Barr\u00e9 syndrome associated with Campylobacter infection in Bangladesh. Neurology 74, 581\u2013587 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1212\/01.wnl.0000265396.87983.bd","volume":"69","author":"I Nachamkin","year":"2007","unstructured":"Nachamkin, I. et al. Patterns of Guillain\u2013Barr\u00e9 syndrome in children: results from a Mexican population. Neurology 69, 1665\u20131671 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby, T. E. et al. An acute axonal form of Guillain\u2013Barr\u00e9 polyneuropathy. Brain 109, 1115\u20131126 (1986).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0404.2001.103005267.x","volume":"103","author":"D Chowdhury","year":"2001","unstructured":"Chowdhury, D. & Arora, A. Axonal Guillain\u2013Barr\u00e9 syndrome: a critical review. Acta Neurol. Scand. 103, 267\u2013277 (2001).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2015192_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M Fisher","year":"1956","unstructured":"Fisher, M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255, 57\u201365 (1956).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015192_CR22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.2010.208538","volume":"81","author":"A Uncini","year":"2010","unstructured":"Uncini, A., Manzoli, C., Notturno, F. & Capasso, M. Pitfalls in electrodiagnosis of Guillain\u2013Barr\u00e9 syndrome subtypes. J. Neurol. Neurosurg. Psychiatry 81, 1157\u20131163 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015192_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","volume":"86","author":"YA Rajabally","year":"2015","unstructured":"Rajabally, Y. A., Durand, M. C., Mitchell, J., Orlikowski, D. & Nicolas, G. Electrophysiological diagnosis of Guillain\u2013Barr\u00e9 syndrome subtype: could a single study suffice? J. Neurol. Neurosurg. Psychiatry 86, 115\u2013119 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015192_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp-2014-308220","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini, A., Zappasodi, F. & Notturno, F. Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle. J. Neurol. Neurosurg. Psychiatry 86, 5\u20138 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015192_CR25","doi-asserted-by":"publisher","unstructured":"Hughes, R. A. & van Doorn, P. A. Corticosteroids for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database of Systematic Reviews, Issue 8. Art. No.: CD001446. http:\/\/dx.doi.org\/10.1002\/14651858.CD001446.pub4 .","DOI":"10.1002\/14651858.CD001446.pub4"},{"key":"BFnrneurol2015192_CR26","doi-asserted-by":"publisher","unstructured":"Hughes, R. A., Swan, A. V. & van Doorn, P. A. Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD002063. http:\/\/dx.doi.org\/10.1002\/14651858.CD002063.pub6 .","DOI":"10.1002\/14651858.CD002063.pub6"},{"key":"BFnrneurol2015192_CR27","doi-asserted-by":"publisher","unstructured":"Hughes, R. A., Pritchard, J. & Hadden, R. D. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD008630. http:\/\/dx.doi.org\/10.1002\/14651858.CD008630.pub3 .","DOI":"10.1002\/14651858.CD008630.pub3"},{"key":"BFnrneurol2015192_CR28","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2014)."},{"key":"BFnrneurol2015192_CR29","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2015)."},{"key":"BFnrneurol2015192_CR30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard, C. et al. Early recognition of poor prognosis in Guillain\u2013Barr\u00e9 syndrome. Neurology 76, 968\u2013975 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","volume":"67","author":"C Walgaard","year":"2010","unstructured":"Walgaard, C. et al. Prediction of respiratory insufficiency in Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 67, 781\u2013787 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR32","unstructured":"IGOS GBS Prognosis Tool [online] , (2015)."},{"key":"BFnrneurol2015192_CR33","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes, R. A., Newsom-Davis, J. M., Perkin, G. D. & Pierce, J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet 2, 750\u2013753 (1978).","journal-title":"Lancet"},{"key":"BFnrneurol2015192_CR34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"IS Merkies","year":"2002","unstructured":"Merkies, I. S. et al. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J. Neurol. Neurosurg. Psychiatry 72, 596\u2013601 (2002).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015192_CR35","doi-asserted-by":"publisher","unstructured":"Lunn, M. P. & Van Den Bergh, P. Outcome measures in neuromuscular disease: is the world still flat? J. Peripher. Nerv. Syst. http:\/\/dx.doi.org\/10.1111\/jns.12119 .","DOI":"10.1111\/jns.12119"},{"key":"BFnrneurol2015192_CR36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1529-8027.2008.00169.x","volume":"13","author":"SI van Nes","year":"2008","unstructured":"van Nes, S. I., Faber, C. G. & Merkies, I. S. Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials. J. Peripher. Nerv. Syst. 13, 136\u2013147 (2008).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"BFnrneurol2015192_CR37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","volume":"76","author":"S van Nes","year":"2011","unstructured":"van Nes, S. I. et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76, 337\u2013345 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR38","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1212\/WNL.0000000000001044","volume":"83","author":"TH Draak","year":"2014","unstructured":"Draak, T. H. et al. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness. Neurology 83, 2124\u20132132 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR39","doi-asserted-by":"publisher","unstructured":"Vanhoutte, E. K. et al. Impairment measures versus inflammatory-RODS in GBS and CIDP: a responsiveness comparison. J. Peripher. Nerv. Syst. http:\/\/dx.doi.org\/10.1111\/jns.12118 .","DOI":"10.1111\/jns.12118"},{"key":"BFnrneurol2015192_CR40","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.20750","volume":"56","author":"JL Salzer","year":"2008","unstructured":"Salzer, J. L., Brophy, P. J. & Peles, E. Molecular domains of myelinated axons in the peripheral nervous system. Glia 56, 1532\u20131540 (2008).","journal-title":"Glia"},{"key":"BFnrneurol2015192_CR41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0000000000000581","volume":"83","author":"H Willison","year":"2014","unstructured":"Willison, H. & Scherer, S. S. Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis. Neurology 83, 106\u2013108 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","volume":"86","author":"EK Mathey","year":"2015","unstructured":"Mathey, E. K. et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J. Neurol. Neurosurg. Psychiatry 86, 973\u2013985 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015192_CR43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A Chiba","year":"1992","unstructured":"Chiba, A., Kusunoki, S., Shimizu, T. & Kanazawa, I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677\u2013679 (1992).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR44","doi-asserted-by":"publisher","unstructured":"Fukami, Y. et al. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum. Eur. J. Neurol. http:\/\/dx.doi.org\/10.1111\/ene.12769 .","DOI":"10.1111\/ene.12769"},{"key":"BFnrneurol2015192_CR45","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","volume":"13","author":"JP Lim","year":"2014","unstructured":"Lim, J. P., Devaux, J. & Yuki, N. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun. Rev. 13, 1070\u20131078 (2014).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneurol2015192_CR46","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","volume":"289","author":"M Labasque","year":"2014","unstructured":"Labasque, M. et al. Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies. J. Biol. Chem. 289, 7907\u20137918 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2015192_CR47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","volume":"73","author":"L Querol","year":"2013","unstructured":"Querol, L. et al. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. 73, 370\u2013380 (2013).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015192_CR48","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura, Y. et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain 138, 1484\u20131491 (2015).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers, M. G. et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur. J. Neurol. 22, 1151\u20131161 (2015).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2015192_CR50","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"HJ Willison","year":"2002","unstructured":"Willison, H. J. & Yuki, N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591\u20132625 (2002).","journal-title":"Brain"},{"key":"BFnrneurol2015192_CR51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/practneurol-2015-001095","volume":"15","author":"AM Rossor","year":"2015","unstructured":"Rossor, A. M., Evans, M. R. & Reilly, M. M. A practical approach to the genetic neuropathies. Pract. Neurol. 15, 187\u2013198 (2015).","journal-title":"Pract. Neurol."},{"key":"BFnrneurol2015192_CR52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","volume":"83","author":"S Sawai","year":"2014","unstructured":"Sawai, S. et al. Moesin is a possible target molecule for cytomegalovirus-related Guillain\u2013Barr\u00e9 syndrome. Neurology 83, 113\u2013117 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2015192_CR53","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.humimm.2014.09.010","volume":"75","author":"K Miyaji","year":"2014","unstructured":"Miyaji, K. et al. Are ERM (ezrin\/radixin\/moesin) proteins targets for autoantibodies in demyelinating neuropathies? Hum. Immunol. 75, 1089\u20131091 (2014).","journal-title":"Hum. Immunol."},{"key":"BFnrneurol2015192_CR54","doi-asserted-by":"publisher","unstructured":"Sinmaz, N. et al. Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry. Ann. N. Y. Acad. Sci. http:\/\/dx.doi.org\/10.1111\/nyas.12764 .","DOI":"10.1111\/nyas.12764"},{"key":"BFnrneurol2015192_CR55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","volume":"223","author":"K Kaida","year":"2010","unstructured":"Kaida, K. & Kusunoki, S. Antibodies to gangliosides and ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: mini-review. J. Neuroimmunol. 223, 5\u201312 (2010).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2015192_CR56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpneuro0001","volume":"1","author":"HJ Willison","year":"2005","unstructured":"Willison, H. J. Ganglioside complexes: new autoantibody targets in Guillain\u2013Barr\u00e9 syndromes. Nat. Clin. Pract. Neurol. 1, 2\u20133 (2005).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol2015192_CR57","doi-asserted-by":"publisher","unstructured":"Rinaldi, S. Complex antibodies provide a simple explanation for the plurality of clinical presentations in the Guillain Barr\u00e9 syndromes. Eur. J. Neurol. http:\/\/dx.doi.org\/10.1111\/ene.12793 .","DOI":"10.1111\/ene.12793"},{"key":"BFnrneurol2015192_CR58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.06.017","volume":"214","author":"G Ogawa","year":"2009","unstructured":"Ogawa, G. et al. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain\u2013Barr\u00e9 syndromes. J. Neuroimmunol. 214, 125\u2013127 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2015192_CR59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/glycob\/cwr139","volume":"22","author":"L Mauri","year":"2012","unstructured":"Mauri, L. et al. Anti-GM1\/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1\u2013GD1a. Glycobiology 22, 352\u2013360 (2012).","journal-title":"Glycobiology"},{"key":"BFnrneurol2015192_CR60","doi-asserted-by":"crossref","first-page":"e82337","DOI":"10.1371\/journal.pone.0082337","volume":"8","author":"S Rinaldi","year":"2013","unstructured":"Rinaldi, S. et al. Antibodies to heteromeric glycolipid complexes in Guillain\u2013Barr\u00e9 syndrome. PLoS ONE 8, e82337 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2015192_CR61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jim.2014.05.005","volume":"408","author":"S Usuki","year":"2014","unstructured":"Usuki, S., O'Brien, D., Rivner, M. H. & Yu, R. K. A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. J. Immunol. Methods 408, 52\u201363 (2014).","journal-title":"J. Immunol. Methods"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:03:25Z","timestamp":1718132605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnrneurol2015192"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.192","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,13]]},"assertion":[{"value":"13 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}